Overview
News
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Team
11-50
employees, estimated range
Backers
1
Y Combinator
Momentum
0/100
no fresh signals
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Jun 2022
Went through Y Combinator
Tractionpublic signals, read monthly
Web presence
top 7%
of 133.2M domains by links, Common Crawl
Backed byfrom the funds' portfolios and accelerator catalogs
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers

A personalized, science-based pain relief app that makes managing chronic pain simple. Track symptoms, get CBT-informed support, and find…

Online chronic pain recovery program designed to get you back to the life you want to live. One-on-one coaching. Real pain reduction…

Miphic. Therapeutic targeting of mitochondria has a great potential in:.

FIRST-IN-CLASS SUPERIOR MAST CELL THERAPEUTICS. First-in-Class Superior Mast Cell Therapeutics targeting mast cells in major diseases areas…

Prevent orthopedic surgeries and chronic pain. Aware Health helps employers reduce MSK costs by 30% with AI-powered care.

Real-time Global Container Tracking and Monitoring Made Simple. Long-lasting sensors that deliver control for decades. Nordic technology.
News
Relevium secures €4.6m from DTIF for knee osteoarthritis treatment
Relevium Medical has been awarded €4.6m from the Irish Government to help it develop its knee osteoarthritis treatment project.
Read more
Report
Making it work: Galway-based Relevium Medical plans €10m Series A round to fund clinical trial research
The start-up medtech company has raised €3.4m to date after developing an injection based form of pain treatment for osteoarthritis of the knee
Read more
Report
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Galway
Ireland
HQ
10-50 est. staff

Y Combinator 




